Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 1/20 | 0.39 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CCR1 | P32246 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.36 |
| ▸ | CCR8 | P51685 | 1/20 | 0.36 |
| ▸ | METAP1 | P53582 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8716895 | 0.83 | KDM4E (0.42) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL8716904 | 0.82 | KDM4E (0.41) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| Dipyridyl SCHEMBL8721461 | 0.79 | KDM4E (0.42) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL28619834 | 0.72 | KDM4E (0.43) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL29141638 | 0.71 | KDM4E (0.42) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL30965294 | 0.71 | KDM4E (0.42) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL608226 | 0.70 | KDM4E (0.48) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL4886435 | 0.69 | SMN1; SMN2 (0.48) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL4152114 | 0.69 | KDM4E (0.48) | LMNASMN1; SMN2KDM4EL3MBTL1POLB | |
| SCHEMBL4392033 | 0.69 | KDM4E (0.39) | LMNASMN1; SMN2KDM4EL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9184428-B2 | Non-aqueous electrolytes for lithium ion batteries | UCHICAGO ARGONNE LLC (US) | 2015-11-10 | — | — | US | claimed |
| US-9012096-B2 | Long life lithium batteries with stabilized electrodes | UCHICAGO ARGONNE, LLC (US) | 2015-04-21 | — | — | US | claimed |
| US-7851092-B2 | Redox shuttles for overcharge protection of lithium batteries | U CHICAGO ARGONNE LLC (US) | 2010-12-14 | — | — | US | claimed |
| WO-2006101779-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES | THE UNIVERSITY OF CHICAGO (US) | 2006-09-28 | — | — | WO | claimed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | claimed |
| WO-2006094069-A2 | NOVEL REDOX SHUTTLES FOR OVERCHARGE PROTECTION OF LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2006-09-08 | — | — | WO | claimed |
| US-20060199080-A1 | Novel redox shuttles for overcharge protection of lithium batteries | THE UNIVERSITY OF CHICAGO | 2006-09-07 | — | — | US | claimed |
| US-20060147809-A1 | Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group | THE UNIVERSITY OF CHICAGO | 2006-07-06 | — | — | US | claimed |
| US-12327844-B2 | Materials to improve the performance of lithium and sodium batteries | UCHICAGO ARGONNE, LLC (US) | 2025-06-10 | — | — | US | disclosed |
| EP-3656010-B1 | PHOSPHORUS-CONTAINING ELECTROLYTES | SIONIC ENERGY INC (US) | 2025-03-26 | — | — | EP | disclosed |
| US-20250079514-A1 | SILYL ENOLATES FOR USE IN LITHIUM BATTERY ELECTROLYTES | UCHICAGO ARGONNE, LLC (US) | 2025-03-06 | — | — | US | disclosed |
| US-12155038-B2 | Modified ionic liquids containing bicyclophosphate moiety | Sionic Energy, Inc. (US) | 2024-11-26 | — | — | US | disclosed |
| US-12021226-B2 | Cathode materials for secondary batteries | UCHICAGO ARGONNE, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3656009-B1 | MODIFIED IONIC LIQUIDS CONTAINING TRIAZINE | NOHMS TECH INC (US) | 2023-11-15 | — | — | EP | disclosed |
| US-20070148545-A1 | Electrode materials and lithium battery systems | THE UNIVERSITY OF CHICAGO | 2007-06-28 | — | — | US | disclosed |
| WO-2006101779-A2 | NON-AQUEOUS ELECTROLYTES FOR LITHIUM ION BATTERIES | THE UNIVERSITY OF CHICAGO (US) | 2006-09-28 | — | — | WO | disclosed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | disclosed |
| WO-2006094069-A2 | NOVEL REDOX SHUTTLES FOR OVERCHARGE PROTECTION OF LITHIUM BATTERIES | UCHICAGO ARGONNE, LLC (US) | 2006-09-08 | — | — | WO | disclosed |
| US-20060199080-A1 | Novel redox shuttles for overcharge protection of lithium batteries | THE UNIVERSITY OF CHICAGO | 2006-09-07 | — | — | US | disclosed |
| US-20060147809-A1 | Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group | THE UNIVERSITY OF CHICAGO | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250079514-A1 | SILYL ENOLATES FOR USE IN LITHIUM BATTERY ELECTROLYTES | SELENOI, SLC10A1, SLC9A3 | LMNA 1424/4885SMN1; SMN2 1955/4885KDM4E 2448/4885 |
| US-12155038-B2 | Modified ionic liquids containing bicyclophosphate moiety | IPMK, PPIP5K2, OSGEP | LMNA 1101/4885SMN1; SMN2 3318/4885KDM4E 2868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.